Global Children Genetic Disease Diagnosis Market 2026 by Company, Regions, Type and Application, Forecast to 2032

September 2026 | 140 pages | ID: G3E6E0934FFDEN
GlobalInfoResearch

US$ 3,480.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
According to our (Global Info Research) latest study, the global Children Genetic Disease Diagnosis market size was valued at US$ 5016 million in 2025 and is forecast to a readjusted size of US$ 8669 million by 2032 with a CAGR of 8.2% during review period.

The gross profit margin of major companies in the industry was approximately 42%–65%.

Child Genetic Disease Diagnosis refers to laboratory testing and clinical interpretation used to identify inherited or de novo genetic disorders in infants, children, and adolescents. It applies chromosomal analysis, targeted gene panels, microarrays, exome sequencing, genome sequencing, and related molecular methods to detect pathogenic variants and support diagnosis, treatment selection, prognosis, and family counseling. Major applications include rare diseases, developmental delay, congenital abnormalities, neurological disorders, metabolic diseases, and hereditary cardiovascular conditions. The scope excludes prenatal testing, adult-only genetic screening, routine newborn biochemical screening without genetic confirmation, ancestry testing, reproductive carrier screening, and genetic research services without clinical diagnostic reporting.

The industrial chain of Child Genetic Disease Diagnosis includes upstream specimen collection products, nucleic acid extraction reagents, sequencing consumables, microarrays, enzymes, reference materials, testing instruments, bioinformatics software, and genomic databases. Midstream covers sample preparation, sequencing or molecular analysis, variant detection, bioinformatics processing, clinical interpretation, report generation, quality control, and laboratory accreditation. Downstream users mainly include pediatric hospitals, general hospitals, genetic clinics, diagnostic laboratories, rare-disease centers, physicians, affected children, and their families. Supporting services include genetic counseling, physician education, data management, and follow-up testing, while prenatal screening, nonclinical research, and consumer ancestry analysis remain outside the core diagnostic chain.

Child genetic disease diagnosis relies on gene detection technology for early screening and confirmation of hereditary disorders in infants and children, supporting targeted intervention and prenatal guidance. Rising public attention to neonatal health expands market space. Future development trends include high-throughput joint testing and cost reduction of detection programs.

Report Scope

This report is a detailed and comprehensive analysis for global Children Genetic Disease Diagnosis market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.

Key Features:

Global Children Genetic Disease Diagnosis market size and forecasts, in consumption value ($ Million), 2021-2032

Global Children Genetic Disease Diagnosis market size and forecasts by region and country, in consumption value ($ Million), 2021-2032

Global Children Genetic Disease Diagnosis market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032

Global Children Genetic Disease Diagnosis market shares of main players, in revenue ($ Million), 2021-2026

The Primary Objectives in This Report Are:

  • To determine the size of the total market opportunity of global and key countries
  • To assess the growth potential for Children Genetic Disease Diagnosis
  • To forecast future growth in each product and end-use market
  • To assess competitive factors affecting the marketplace
  • This report profiles key players in the global Children Genetic Disease Diagnosis market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include GeneDx Holdings Corp., Labcorp, Ambry Genetics, PreventionGenetics, Blueprint Genetics, Baylor Genetics, CENTOGENE N.V., Variantyx, Inc., Fulgent Genetics, Inc., GeneSprout, Inc., etc.
  • This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Market segmentation

  • Children Genetic Disease Diagnosis market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type

  • Prenatal Diagnosis
  • Screening for Single Gene Genetic Disease
  • Preimplantation Genetic Testing
  • Others

Market segment by Specimen Type

  • Blood-based Testing
  • Buccal Swab and Saliva-based Testing
  • Tissue and Prenatal Specimen-based Testing

Market segment by Turnaround Time

  • Rapid Testing?≤3 Days?
  • Standard Testing??3–14 Days?
  • Extended Testing??14 Days?

Market segment by Application

  • Chromosomal Disorders
  • Monogenic Disorders
  • Mitochondrial Disorders
  • Other

Market segment by players, this report covers

  • GeneDx Holdings Corp.
  • Labcorp
  • Ambry Genetics
  • PreventionGenetics
  • Blueprint Genetics
  • Baylor Genetics
  • CENTOGENE N.V.
  • Variantyx, Inc.
  • Fulgent Genetics, Inc.
  • GeneSprout, Inc.
  • BGI Genomics Co., Ltd.
  • Berry Genomics Co., Ltd.
  • Annoroad Gene Technology Co., Ltd.
  • MyGenostics Inc.
  • CapitalBio Corporation
  • Guangzhou KingMed Diagnostics Group Co., Ltd.
  • Dian Diagnostics Group Co., Ltd.
  • Suzhou GeneSky Clinical Laboratory Co., Ltd.

Market segment by regions, regional analysis covers

  • North America (United States, Canada and Mexico)
  • Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
  • Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
  • South America (Brazil, Rest of South America)
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

Chapter Outline

Chapter 1, to describe Children Genetic Disease Diagnosis product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top players of Children Genetic Disease Diagnosis, with revenue, gross margin, and global market share of Children Genetic Disease Diagnosis from 2021 to 2026.

Chapter 3, the Children Genetic Disease Diagnosis competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.

Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.

Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Children Genetic Disease Diagnosis market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.

Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.

Chapter 12, the key raw materials and key suppliers, and industry chain of Children Genetic Disease Diagnosis.

Chapter 13, to describe Children Genetic Disease Diagnosis research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Children Genetic Disease Diagnosis by Type
  1.3.1 Overview: Global Children Genetic Disease Diagnosis Market Size by Type: 2021 Versus 2025 Versus 2032
  1.3.2 Global Children Genetic Disease Diagnosis Consumption Value Market Share by Type in 2025
  1.3.3 Prenatal Diagnosis
  1.3.4 Screening for Single Gene Genetic Disease
  1.3.5 Preimplantation Genetic Testing
  1.3.6 Others
1.4 Classification of Children Genetic Disease Diagnosis by Specimen Type
  1.4.1 Overview: Global Children Genetic Disease Diagnosis Market Size by Specimen Type: 2021 Versus 2025 Versus 2032
  1.4.2 Global Children Genetic Disease Diagnosis Consumption Value Market Share by Specimen Type in 2025
  1.4.3 Blood-based Testing
  1.4.4 Buccal Swab and Saliva-based Testing
  1.4.5 Tissue and Prenatal Specimen-based Testing
1.5 Classification of Children Genetic Disease Diagnosis by Turnaround Time
  1.5.1 Overview: Global Children Genetic Disease Diagnosis Market Size by Turnaround Time: 2021 Versus 2025 Versus 2032
  1.5.2 Global Children Genetic Disease Diagnosis Consumption Value Market Share by Turnaround Time in 2025
  1.5.3 Rapid Testing?≤3 Days?
  1.5.4 Standard Testing??3–14 Days?
  1.5.5 Extended Testing??14 Days?
1.6 Global Children Genetic Disease Diagnosis Market by Application
  1.6.1 Overview: Global Children Genetic Disease Diagnosis Market Size by Application: 2021 Versus 2025 Versus 2032
  1.6.2 Chromosomal Disorders
  1.6.3 Monogenic Disorders
  1.6.4 Mitochondrial Disorders
  1.6.5 Other
1.7 Global Children Genetic Disease Diagnosis Market Size & Forecast
1.8 Global Children Genetic Disease Diagnosis Market Size and Forecast by Region
  1.8.1 Global Children Genetic Disease Diagnosis Market Size by Region: 2021 VS 2025 VS 2032
  1.8.2 Global Children Genetic Disease Diagnosis Market Size by Region, (2021-2032)
  1.8.3 North America Children Genetic Disease Diagnosis Market Size and Prospect (2021-2032)
  1.8.4 Europe Children Genetic Disease Diagnosis Market Size and Prospect (2021-2032)
  1.8.5 Asia-Pacific Children Genetic Disease Diagnosis Market Size and Prospect (2021-2032)
  1.8.6 South America Children Genetic Disease Diagnosis Market Size and Prospect (2021-2032)
  1.8.7 Middle East & Africa Children Genetic Disease Diagnosis Market Size and Prospect (2021-2032)

2 COMPANY PROFILES
2.1 GeneDx Holdings Corp.
  2.1.1 GeneDx Holdings Corp. Details
  2.1.2 GeneDx Holdings Corp. Major Business
  2.1.3 GeneDx Holdings Corp. Children Genetic Disease Diagnosis Product and Solutions
  2.1.4 GeneDx Holdings Corp. Children Genetic Disease Diagnosis Revenue, Gross Margin and Market Share (2021-2026)
  2.1.5 GeneDx Holdings Corp. Recent Developments and Future Plans
2.2 Labcorp
  2.2.1 Labcorp Details
  2.2.2 Labcorp Major Business
  2.2.3 Labcorp Children Genetic Disease Diagnosis Product and Solutions
  2.2.4 Labcorp Children Genetic Disease Diagnosis Revenue, Gross Margin and Market Share (2021-2026)
  2.2.5 Labcorp Recent Developments and Future Plans
2.3 Ambry Genetics
  2.3.1 Ambry Genetics Details
  2.3.2 Ambry Genetics Major Business
  2.3.3 Ambry Genetics Children Genetic Disease Diagnosis Product and Solutions
  2.3.4 Ambry Genetics Children Genetic Disease Diagnosis Revenue, Gross Margin and Market Share (2021-2026)
  2.3.5 Ambry Genetics Recent Developments and Future Plans
2.4 PreventionGenetics
  2.4.1 PreventionGenetics Details
  2.4.2 PreventionGenetics Major Business
  2.4.3 PreventionGenetics Children Genetic Disease Diagnosis Product and Solutions
  2.4.4 PreventionGenetics Children Genetic Disease Diagnosis Revenue, Gross Margin and Market Share (2021-2026)
  2.4.5 PreventionGenetics Recent Developments and Future Plans
2.5 Blueprint Genetics
  2.5.1 Blueprint Genetics Details
  2.5.2 Blueprint Genetics Major Business
  2.5.3 Blueprint Genetics Children Genetic Disease Diagnosis Product and Solutions
  2.5.4 Blueprint Genetics Children Genetic Disease Diagnosis Revenue, Gross Margin and Market Share (2021-2026)
  2.5.5 Blueprint Genetics Recent Developments and Future Plans
2.6 Baylor Genetics
  2.6.1 Baylor Genetics Details
  2.6.2 Baylor Genetics Major Business
  2.6.3 Baylor Genetics Children Genetic Disease Diagnosis Product and Solutions
  2.6.4 Baylor Genetics Children Genetic Disease Diagnosis Revenue, Gross Margin and Market Share (2021-2026)
  2.6.5 Baylor Genetics Recent Developments and Future Plans
2.7 CENTOGENE N.V.
  2.7.1 CENTOGENE N.V. Details
  2.7.2 CENTOGENE N.V. Major Business
  2.7.3 CENTOGENE N.V. Children Genetic Disease Diagnosis Product and Solutions
  2.7.4 CENTOGENE N.V. Children Genetic Disease Diagnosis Revenue, Gross Margin and Market Share (2021-2026)
  2.7.5 CENTOGENE N.V. Recent Developments and Future Plans
2.8 Variantyx, Inc.
  2.8.1 Variantyx, Inc. Details
  2.8.2 Variantyx, Inc. Major Business
  2.8.3 Variantyx, Inc. Children Genetic Disease Diagnosis Product and Solutions
  2.8.4 Variantyx, Inc. Children Genetic Disease Diagnosis Revenue, Gross Margin and Market Share (2021-2026)
  2.8.5 Variantyx, Inc. Recent Developments and Future Plans
2.9 Fulgent Genetics, Inc.
  2.9.1 Fulgent Genetics, Inc. Details
  2.9.2 Fulgent Genetics, Inc. Major Business
  2.9.3 Fulgent Genetics, Inc. Children Genetic Disease Diagnosis Product and Solutions
  2.9.4 Fulgent Genetics, Inc. Children Genetic Disease Diagnosis Revenue, Gross Margin and Market Share (2021-2026)
  2.9.5 Fulgent Genetics, Inc. Recent Developments and Future Plans
2.10 GeneSprout, Inc.
  2.10.1 GeneSprout, Inc. Details
  2.10.2 GeneSprout, Inc. Major Business
  2.10.3 GeneSprout, Inc. Children Genetic Disease Diagnosis Product and Solutions
  2.10.4 GeneSprout, Inc. Children Genetic Disease Diagnosis Revenue, Gross Margin and Market Share (2021-2026)
  2.10.5 GeneSprout, Inc. Recent Developments and Future Plans
2.11 BGI Genomics Co., Ltd.
  2.11.1 BGI Genomics Co., Ltd. Details
  2.11.2 BGI Genomics Co., Ltd. Major Business
  2.11.3 BGI Genomics Co., Ltd. Children Genetic Disease Diagnosis Product and Solutions
  2.11.4 BGI Genomics Co., Ltd. Children Genetic Disease Diagnosis Revenue, Gross Margin and Market Share (2021-2026)
  2.11.5 BGI Genomics Co., Ltd. Recent Developments and Future Plans
2.12 Berry Genomics Co., Ltd.
  2.12.1 Berry Genomics Co., Ltd. Details
  2.12.2 Berry Genomics Co., Ltd. Major Business
  2.12.3 Berry Genomics Co., Ltd. Children Genetic Disease Diagnosis Product and Solutions
  2.12.4 Berry Genomics Co., Ltd. Children Genetic Disease Diagnosis Revenue, Gross Margin and Market Share (2021-2026)
  2.12.5 Berry Genomics Co., Ltd. Recent Developments and Future Plans
2.13 Annoroad Gene Technology Co., Ltd.
  2.13.1 Annoroad Gene Technology Co., Ltd. Details
  2.13.2 Annoroad Gene Technology Co., Ltd. Major Business
  2.13.3 Annoroad Gene Technology Co., Ltd. Children Genetic Disease Diagnosis Product and Solutions
  2.13.4 Annoroad Gene Technology Co., Ltd. Children Genetic Disease Diagnosis Revenue, Gross Margin and Market Share (2021-2026)
  2.13.5 Annoroad Gene Technology Co., Ltd. Recent Developments and Future Plans
2.14 MyGenostics Inc.
  2.14.1 MyGenostics Inc. Details
  2.14.2 MyGenostics Inc. Major Business
  2.14.3 MyGenostics Inc. Children Genetic Disease Diagnosis Product and Solutions
  2.14.4 MyGenostics Inc. Children Genetic Disease Diagnosis Revenue, Gross Margin and Market Share (2021-2026)
  2.14.5 MyGenostics Inc. Recent Developments and Future Plans
2.15 CapitalBio Corporation
  2.15.1 CapitalBio Corporation Details
  2.15.2 CapitalBio Corporation Major Business
  2.15.3 CapitalBio Corporation Children Genetic Disease Diagnosis Product and Solutions
  2.15.4 CapitalBio Corporation Children Genetic Disease Diagnosis Revenue, Gross Margin and Market Share (2021-2026)
  2.15.5 CapitalBio Corporation Recent Developments and Future Plans
2.16 Guangzhou KingMed Diagnostics Group Co., Ltd.
  2.16.1 Guangzhou KingMed Diagnostics Group Co., Ltd. Details
  2.16.2 Guangzhou KingMed Diagnostics Group Co., Ltd. Major Business
  2.16.3 Guangzhou KingMed Diagnostics Group Co., Ltd. Children Genetic Disease Diagnosis Product and Solutions
  2.16.4 Guangzhou KingMed Diagnostics Group Co., Ltd. Children Genetic Disease Diagnosis Revenue, Gross Margin and Market Share (2021-2026)
  2.16.5 Guangzhou KingMed Diagnostics Group Co., Ltd. Recent Developments and Future Plans
2.17 Dian Diagnostics Group Co., Ltd.
  2.17.1 Dian Diagnostics Group Co., Ltd. Details
  2.17.2 Dian Diagnostics Group Co., Ltd. Major Business
  2.17.3 Dian Diagnostics Group Co., Ltd. Children Genetic Disease Diagnosis Product and Solutions
  2.17.4 Dian Diagnostics Group Co., Ltd. Children Genetic Disease Diagnosis Revenue, Gross Margin and Market Share (2021-2026)
  2.17.5 Dian Diagnostics Group Co., Ltd. Recent Developments and Future Plans
2.18 Suzhou GeneSky Clinical Laboratory Co., Ltd.
  2.18.1 Suzhou GeneSky Clinical Laboratory Co., Ltd. Details
  2.18.2 Suzhou GeneSky Clinical Laboratory Co., Ltd. Major Business
  2.18.3 Suzhou GeneSky Clinical Laboratory Co., Ltd. Children Genetic Disease Diagnosis Product and Solutions
  2.18.4 Suzhou GeneSky Clinical Laboratory Co., Ltd. Children Genetic Disease Diagnosis Revenue, Gross Margin and Market Share (2021-2026)
  2.18.5 Suzhou GeneSky Clinical Laboratory Co., Ltd. Recent Developments and Future Plans

3 MARKET COMPETITION, BY PLAYERS
3.1 Global Children Genetic Disease Diagnosis Revenue and Share by Players (2021-2026)
3.2 Market Share Analysis (2025)
  3.2.1 Market Share of Children Genetic Disease Diagnosis by Company Revenue
  3.2.2 Top 3 Children Genetic Disease Diagnosis Players Market Share in 2025
  3.2.3 Top 6 Children Genetic Disease Diagnosis Players Market Share in 2025
3.3 Children Genetic Disease Diagnosis Market: Overall Company Footprint Analysis
  3.3.1 Children Genetic Disease Diagnosis Market: Region Footprint
  3.3.2 Children Genetic Disease Diagnosis Market: Company Product Type Footprint
  3.3.3 Children Genetic Disease Diagnosis Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations

4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Children Genetic Disease Diagnosis Consumption Value and Market Share by Type (2021-2026)
4.2 Global Children Genetic Disease Diagnosis Market Forecast by Type (2027-2032)

5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Children Genetic Disease Diagnosis Consumption Value Market Share by Application (2021-2026)
5.2 Global Children Genetic Disease Diagnosis Market Forecast by Application (2027-2032)

6 NORTH AMERICA
6.1 North America Children Genetic Disease Diagnosis Consumption Value by Type (2021-2032)
6.2 North America Children Genetic Disease Diagnosis Market Size by Application (2021-2032)
6.3 North America Children Genetic Disease Diagnosis Market Size by Country
  6.3.1 North America Children Genetic Disease Diagnosis Consumption Value by Country (2021-2032)
  6.3.2 United States Children Genetic Disease Diagnosis Market Size and Forecast (2021-2032)
  6.3.3 Canada Children Genetic Disease Diagnosis Market Size and Forecast (2021-2032)
  6.3.4 Mexico Children Genetic Disease Diagnosis Market Size and Forecast (2021-2032)

7 EUROPE
7.1 Europe Children Genetic Disease Diagnosis Consumption Value by Type (2021-2032)
7.2 Europe Children Genetic Disease Diagnosis Consumption Value by Application (2021-2032)
7.3 Europe Children Genetic Disease Diagnosis Market Size by Country
  7.3.1 Europe Children Genetic Disease Diagnosis Consumption Value by Country (2021-2032)
  7.3.2 Germany Children Genetic Disease Diagnosis Market Size and Forecast (2021-2032)
  7.3.3 France Children Genetic Disease Diagnosis Market Size and Forecast (2021-2032)
  7.3.4 United Kingdom Children Genetic Disease Diagnosis Market Size and Forecast (2021-2032)
  7.3.5 Russia Children Genetic Disease Diagnosis Market Size and Forecast (2021-2032)
  7.3.6 Italy Children Genetic Disease Diagnosis Market Size and Forecast (2021-2032)

8 ASIA-PACIFIC
8.1 Asia-Pacific Children Genetic Disease Diagnosis Consumption Value by Type (2021-2032)
8.2 Asia-Pacific Children Genetic Disease Diagnosis Consumption Value by Application (2021-2032)
8.3 Asia-Pacific Children Genetic Disease Diagnosis Market Size by Region
  8.3.1 Asia-Pacific Children Genetic Disease Diagnosis Consumption Value by Region (2021-2032)
  8.3.2 China Children Genetic Disease Diagnosis Market Size and Forecast (2021-2032)
  8.3.3 Japan Children Genetic Disease Diagnosis Market Size and Forecast (2021-2032)
  8.3.4 South Korea Children Genetic Disease Diagnosis Market Size and Forecast (2021-2032)
  8.3.5 India Children Genetic Disease Diagnosis Market Size and Forecast (2021-2032)
  8.3.6 Southeast Asia Children Genetic Disease Diagnosis Market Size and Forecast (2021-2032)
  8.3.7 Australia Children Genetic Disease Diagnosis Market Size and Forecast (2021-2032)

9 SOUTH AMERICA
9.1 South America Children Genetic Disease Diagnosis Consumption Value by Type (2021-2032)
9.2 South America Children Genetic Disease Diagnosis Consumption Value by Application (2021-2032)
9.3 South America Children Genetic Disease Diagnosis Market Size by Country
  9.3.1 South America Children Genetic Disease Diagnosis Consumption Value by Country (2021-2032)
  9.3.2 Brazil Children Genetic Disease Diagnosis Market Size and Forecast (2021-2032)
  9.3.3 Argentina Children Genetic Disease Diagnosis Market Size and Forecast (2021-2032)

10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Children Genetic Disease Diagnosis Consumption Value by Type (2021-2032)
10.2 Middle East & Africa Children Genetic Disease Diagnosis Consumption Value by Application (2021-2032)
10.3 Middle East & Africa Children Genetic Disease Diagnosis Market Size by Country
  10.3.1 Middle East & Africa Children Genetic Disease Diagnosis Consumption Value by Country (2021-2032)
  10.3.2 Turkey Children Genetic Disease Diagnosis Market Size and Forecast (2021-2032)
  10.3.3 Saudi Arabia Children Genetic Disease Diagnosis Market Size and Forecast (2021-2032)
  10.3.4 UAE Children Genetic Disease Diagnosis Market Size and Forecast (2021-2032)

11 MARKET DYNAMICS
11.1 Children Genetic Disease Diagnosis Market Drivers
11.2 Children Genetic Disease Diagnosis Market Restraints
11.3 Children Genetic Disease Diagnosis Trends Analysis
11.4 Porters Five Forces Analysis
  11.4.1 Threat of New Entrants
  11.4.2 Bargaining Power of Suppliers
  11.4.3 Bargaining Power of Buyers
  11.4.4 Threat of Substitutes
  11.4.5 Competitive Rivalry

12 INDUSTRY CHAIN ANALYSIS
12.1 Children Genetic Disease Diagnosis Industry Chain
12.2 Children Genetic Disease Diagnosis Upstream Analysis
12.3 Children Genetic Disease Diagnosis Midstream Analysis
12.4 Children Genetic Disease Diagnosis Downstream Analysis

13 RESEARCH FINDINGS AND CONCLUSION

14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES

Table 1. Global Children Genetic Disease Diagnosis Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Table 2. Global Children Genetic Disease Diagnosis Consumption Value by Specimen Type, (USD Million), 2021 & 2025 & 2032
Table 3. Global Children Genetic Disease Diagnosis Consumption Value by Turnaround Time, (USD Million), 2021 & 2025 & 2032
Table 4. Global Children Genetic Disease Diagnosis Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 5. Global Children Genetic Disease Diagnosis Consumption Value by Region (2021-2026) & (USD Million)
Table 6. Global Children Genetic Disease Diagnosis Consumption Value by Region (2027-2032) & (USD Million)
Table 7. GeneDx Holdings Corp. Company Information, Head Office, and Major Competitors
Table 8. GeneDx Holdings Corp. Major Business
Table 9. GeneDx Holdings Corp. Children Genetic Disease Diagnosis Product and Solutions
Table 10. GeneDx Holdings Corp. Children Genetic Disease Diagnosis Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 11. GeneDx Holdings Corp. Recent Developments and Future Plans
Table 12. Labcorp Company Information, Head Office, and Major Competitors
Table 13. Labcorp Major Business
Table 14. Labcorp Children Genetic Disease Diagnosis Product and Solutions
Table 15. Labcorp Children Genetic Disease Diagnosis Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 16. Labcorp Recent Developments and Future Plans
Table 17. Ambry Genetics Company Information, Head Office, and Major Competitors
Table 18. Ambry Genetics Major Business
Table 19. Ambry Genetics Children Genetic Disease Diagnosis Product and Solutions
Table 20. Ambry Genetics Children Genetic Disease Diagnosis Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 21. PreventionGenetics Company Information, Head Office, and Major Competitors
Table 22. PreventionGenetics Major Business
Table 23. PreventionGenetics Children Genetic Disease Diagnosis Product and Solutions
Table 24. PreventionGenetics Children Genetic Disease Diagnosis Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 25. PreventionGenetics Recent Developments and Future Plans
Table 26. Blueprint Genetics Company Information, Head Office, and Major Competitors
Table 27. Blueprint Genetics Major Business
Table 28. Blueprint Genetics Children Genetic Disease Diagnosis Product and Solutions
Table 29. Blueprint Genetics Children Genetic Disease Diagnosis Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 30. Blueprint Genetics Recent Developments and Future Plans
Table 31. Baylor Genetics Company Information, Head Office, and Major Competitors
Table 32. Baylor Genetics Major Business
Table 33. Baylor Genetics Children Genetic Disease Diagnosis Product and Solutions
Table 34. Baylor Genetics Children Genetic Disease Diagnosis Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 35. Baylor Genetics Recent Developments and Future Plans
Table 36. CENTOGENE N.V. Company Information, Head Office, and Major Competitors
Table 37. CENTOGENE N.V. Major Business
Table 38. CENTOGENE N.V. Children Genetic Disease Diagnosis Product and Solutions
Table 39. CENTOGENE N.V. Children Genetic Disease Diagnosis Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 40. CENTOGENE N.V. Recent Developments and Future Plans
Table 41. Variantyx, Inc. Company Information, Head Office, and Major Competitors
Table 42. Variantyx, Inc. Major Business
Table 43. Variantyx, Inc. Children Genetic Disease Diagnosis Product and Solutions
Table 44. Variantyx, Inc. Children Genetic Disease Diagnosis Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 45. Variantyx, Inc. Recent Developments and Future Plans
Table 46. Fulgent Genetics, Inc. Company Information, Head Office, and Major Competitors
Table 47. Fulgent Genetics, Inc. Major Business
Table 48. Fulgent Genetics, Inc. Children Genetic Disease Diagnosis Product and Solutions
Table 49. Fulgent Genetics, Inc. Children Genetic Disease Diagnosis Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 50. Fulgent Genetics, Inc. Recent Developments and Future Plans
Table 51. GeneSprout, Inc. Company Information, Head Office, and Major Competitors
Table 52. GeneSprout, Inc. Major Business
Table 53. GeneSprout, Inc. Children Genetic Disease Diagnosis Product and Solutions
Table 54. GeneSprout, Inc. Children Genetic Disease Diagnosis Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 55. GeneSprout, Inc. Recent Developments and Future Plans
Table 56. BGI Genomics Co., Ltd. Company Information, Head Office, and Major Competitors
Table 57. BGI Genomics Co., Ltd. Major Business
Table 58. BGI Genomics Co., Ltd. Children Genetic Disease Diagnosis Product and Solutions
Table 59. BGI Genomics Co., Ltd. Children Genetic Disease Diagnosis Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 60. BGI Genomics Co., Ltd. Recent Developments and Future Plans
Table 61. Berry Genomics Co., Ltd. Company Information, Head Office, and Major Competitors
Table 62. Berry Genomics Co., Ltd. Major Business
Table 63. Berry Genomics Co., Ltd. Children Genetic Disease Diagnosis Product and Solutions
Table 64. Berry Genomics Co., Ltd. Children Genetic Disease Diagnosis Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 65. Berry Genomics Co., Ltd. Recent Developments and Future Plans
Table 66. Annoroad Gene Technology Co., Ltd. Company Information, Head Office, and Major Competitors
Table 67. Annoroad Gene Technology Co., Ltd. Major Business
Table 68. Annoroad Gene Technology Co., Ltd. Children Genetic Disease Diagnosis Product and Solutions
Table 69. Annoroad Gene Technology Co., Ltd. Children Genetic Disease Diagnosis Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 70. Annoroad Gene Technology Co., Ltd. Recent Developments and Future Plans
Table 71. MyGenostics Inc. Company Information, Head Office, and Major Competitors
Table 72. MyGenostics Inc. Major Business
Table 73. MyGenostics Inc. Children Genetic Disease Diagnosis Product and Solutions
Table 74. MyGenostics Inc. Children Genetic Disease Diagnosis Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 75. MyGenostics Inc. Recent Developments and Future Plans
Table 76. CapitalBio Corporation Company Information, Head Office, and Major Competitors
Table 77. CapitalBio Corporation Major Business
Table 78. CapitalBio Corporation Children Genetic Disease Diagnosis Product and Solutions
Table 79. CapitalBio Corporation Children Genetic Disease Diagnosis Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 80. CapitalBio Corporation Recent Developments and Future Plans
Table 81. Guangzhou KingMed Diagnostics Group Co., Ltd. Company Information, Head Office, and Major Competitors
Table 82. Guangzhou KingMed Diagnostics Group Co., Ltd. Major Business
Table 83. Guangzhou KingMed Diagnostics Group Co., Ltd. Children Genetic Disease Diagnosis Product and Solutions
Table 84. Guangzhou KingMed Diagnostics Group Co., Ltd. Children Genetic Disease Diagnosis Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 85. Guangzhou KingMed Diagnostics Group Co., Ltd. Recent Developments and Future Plans
Table 86. Dian Diagnostics Group Co., Ltd. Company Information, Head Office, and Major Competitors
Table 87. Dian Diagnostics Group Co., Ltd. Major Business
Table 88. Dian Diagnostics Group Co., Ltd. Children Genetic Disease Diagnosis Product and Solutions
Table 89. Dian Diagnostics Group Co., Ltd. Children Genetic Disease Diagnosis Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 90. Dian Diagnostics Group Co., Ltd. Recent Developments and Future Plans
Table 91. Suzhou GeneSky Clinical Laboratory Co., Ltd. Company Information, Head Office, and Major Competitors
Table 92. Suzhou GeneSky Clinical Laboratory Co., Ltd. Major Business
Table 93. Suzhou GeneSky Clinical Laboratory Co., Ltd. Children Genetic Disease Diagnosis Product and Solutions
Table 94. Suzhou GeneSky Clinical Laboratory Co., Ltd. Children Genetic Disease Diagnosis Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 95. Suzhou GeneSky Clinical Laboratory Co., Ltd. Recent Developments and Future Plans
Table 96. Global Children Genetic Disease Diagnosis Revenue (USD Million) by Players (2021-2026)
Table 97. Global Children Genetic Disease Diagnosis Revenue Share by Players (2021-2026)
Table 98. Breakdown of Children Genetic Disease Diagnosis by Company Type (Tier 1, Tier 2, and Tier 3)
Table 99. Market Position of Players in Children Genetic Disease Diagnosis, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 100. Head Office of Key Children Genetic Disease Diagnosis Players
Table 101. Children Genetic Disease Diagnosis Market: Company Product Type Footprint
Table 102. Children Genetic Disease Diagnosis Market: Company Product Application Footprint
Table 103. Children Genetic Disease Diagnosis New Market Entrants and Barriers to Market Entry
Table 104. Children Genetic Disease Diagnosis Mergers, Acquisition, Agreements, and Collaborations
Table 105. Global Children Genetic Disease Diagnosis Consumption Value (USD Million) by Type (2021-2026)
Table 106. Global Children Genetic Disease Diagnosis Consumption Value Share by Type (2021-2026)
Table 107. Global Children Genetic Disease Diagnosis Consumption Value Forecast by Type (2027-2032)
Table 108. Global Children Genetic Disease Diagnosis Consumption Value by Application (2021-2026)
Table 109. Global Children Genetic Disease Diagnosis Consumption Value Forecast by Application (2027-2032)
Table 110. North America Children Genetic Disease Diagnosis Consumption Value by Type (2021-2026) & (USD Million)
Table 111. North America Children Genetic Disease Diagnosis Consumption Value by Type (2027-2032) & (USD Million)
Table 112. North America Children Genetic Disease Diagnosis Consumption Value by Application (2021-2026) & (USD Million)
Table 113. North America Children Genetic Disease Diagnosis Consumption Value by Application (2027-2032) & (USD Million)
Table 114. North America Children Genetic Disease Diagnosis Consumption Value by Country (2021-2026) & (USD Million)
Table 115. North America Children Genetic Disease Diagnosis Consumption Value by Country (2027-2032) & (USD Million)
Table 116. Europe Children Genetic Disease Diagnosis Consumption Value by Type (2021-2026) & (USD Million)
Table 117. Europe Children Genetic Disease Diagnosis Consumption Value by Type (2027-2032) & (USD Million)
Table 118. Europe Children Genetic Disease Diagnosis Consumption Value by Application (2021-2026) & (USD Million)
Table 119. Europe Children Genetic Disease Diagnosis Consumption Value by Application (2027-2032) & (USD Million)
Table 120. Europe Children Genetic Disease Diagnosis Consumption Value by Country (2021-2026) & (USD Million)
Table 121. Europe Children Genetic Disease Diagnosis Consumption Value by Country (2027-2032) & (USD Million)
Table 122. Asia-Pacific Children Genetic Disease Diagnosis Consumption Value by Type (2021-2026) & (USD Million)
Table 123. Asia-Pacific Children Genetic Disease Diagnosis Consumption Value by Type (2027-2032) & (USD Million)
Table 124. Asia-Pacific Children Genetic Disease Diagnosis Consumption Value by Application (2021-2026) & (USD Million)
Table 125. Asia-Pacific Children Genetic Disease Diagnosis Consumption Value by Application (2027-2032) & (USD Million)
Table 126. Asia-Pacific Children Genetic Disease Diagnosis Consumption Value by Region (2021-2026) & (USD Million)
Table 127. Asia-Pacific Children Genetic Disease Diagnosis Consumption Value by Region (2027-2032) & (USD Million)
Table 128. South America Children Genetic Disease Diagnosis Consumption Value by Type (2021-2026) & (USD Million)
Table 129. South America Children Genetic Disease Diagnosis Consumption Value by Type (2027-2032) & (USD Million)
Table 130. South America Children Genetic Disease Diagnosis Consumption Value by Application (2021-2026) & (USD Million)
Table 131. South America Children Genetic Disease Diagnosis Consumption Value by Application (2027-2032) & (USD Million)
Table 132. South America Children Genetic Disease Diagnosis Consumption Value by Country (2021-2026) & (USD Million)
Table 133. South America Children Genetic Disease Diagnosis Consumption Value by Country (2027-2032) & (USD Million)
Table 134. Middle East & Africa Children Genetic Disease Diagnosis Consumption Value by Type (2021-2026) & (USD Million)
Table 135. Middle East & Africa Children Genetic Disease Diagnosis Consumption Value by Type (2027-2032) & (USD Million)
Table 136. Middle East & Africa Children Genetic Disease Diagnosis Consumption Value by Application (2021-2026) & (USD Million)
Table 137. Middle East & Africa Children Genetic Disease Diagnosis Consumption Value by Application (2027-2032) & (USD Million)
Table 138. Middle East & Africa Children Genetic Disease Diagnosis Consumption Value by Country (2021-2026) & (USD Million)
Table 139. Middle East & Africa Children Genetic Disease Diagnosis Consumption Value by Country (2027-2032) & (USD Million)
Table 140. Global Key Players of Children Genetic Disease Diagnosis Upstream (Raw Materials)
Table 141. Global Children Genetic Disease Diagnosis Typical Customers

LIST OF FIGURES

Figure 1. Children Genetic Disease Diagnosis Picture
Figure 2. Global Children Genetic Disease Diagnosis Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 3. Global Children Genetic Disease Diagnosis Consumption Value Market Share by Type in 2025
Figure 4. Prenatal Diagnosis
Figure 5. Screening for Single Gene Genetic Disease
Figure 6. Preimplantation Genetic Testing
Figure 7. Others
Figure 8. Global Children Genetic Disease Diagnosis Consumption Value by Specimen Type, (USD Million), 2021 & 2025 & 2032
Figure 9. Global Children Genetic Disease Diagnosis Consumption Value Market Share by Specimen Type in 2025
Figure 10. Blood-based Testing
Figure 11. Buccal Swab and Saliva-based Testing
Figure 12. Tissue and Prenatal Specimen-based Testing
Figure 13. Global Children Genetic Disease Diagnosis Consumption Value by Turnaround Time, (USD Million), 2021 & 2025 & 2032
Figure 14. Global Children Genetic Disease Diagnosis Consumption Value Market Share by Turnaround Time in 2025
Figure 15. Rapid Testing?≤3 Days?
Figure 16. Standard Testing??3–14 Days?
Figure 17. Extended Testing??14 Days?
Figure 18. Global Children Genetic Disease Diagnosis Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 19. Children Genetic Disease Diagnosis Consumption Value Market Share by Application in 2025
Figure 20. Chromosomal Disorders Picture
Figure 21. Monogenic Disorders Picture
Figure 22. Mitochondrial Disorders Picture
Figure 23. Other Picture
Figure 24. Global Children Genetic Disease Diagnosis Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 25. Global Children Genetic Disease Diagnosis Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 26. Global Market Children Genetic Disease Diagnosis Consumption Value (USD Million) Comparison by Region (2021 VS 2025 VS 2032)
Figure 27. Global Children Genetic Disease Diagnosis Consumption Value Market Share by Region (2021-2032)
Figure 28. Global Children Genetic Disease Diagnosis Consumption Value Market Share by Region in 2025
Figure 29. North America Children Genetic Disease Diagnosis Consumption Value (2021-2032) & (USD Million)
Figure 30. Europe Children Genetic Disease Diagnosis Consumption Value (2021-2032) & (USD Million)
Figure 31. Asia-Pacific Children Genetic Disease Diagnosis Consumption Value (2021-2032) & (USD Million)
Figure 32. South America Children Genetic Disease Diagnosis Consumption Value (2021-2032) & (USD Million)
Figure 33. Middle East & Africa Children Genetic Disease Diagnosis Consumption Value (2021-2032) & (USD Million)
Figure 34. Company Three Recent Developments and Future Plans
Figure 35. Global Children Genetic Disease Diagnosis Revenue Share by Players in 2025
Figure 36. Children Genetic Disease Diagnosis Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2025
Figure 37. Market Share of Children Genetic Disease Diagnosis by Player Revenue in 2025
Figure 38. Top 3 Children Genetic Disease Diagnosis Players Market Share in 2025
Figure 39. Top 6 Children Genetic Disease Diagnosis Players Market Share in 2025
Figure 40. Global Children Genetic Disease Diagnosis Consumption Value Share by Type (2021-2026)
Figure 41. Global Children Genetic Disease Diagnosis Market Share Forecast by Type (2027-2032)
Figure 42. Global Children Genetic Disease Diagnosis Consumption Value Share by Application (2021-2026)
Figure 43. Global Children Genetic Disease Diagnosis Market Share Forecast by Application (2027-2032)
Figure 44. North America Children Genetic Disease Diagnosis Consumption Value Market Share by Type (2021-2032)
Figure 45. North America Children Genetic Disease Diagnosis Consumption Value Market Share by Application (2021-2032)
Figure 46. North America Children Genetic Disease Diagnosis Consumption Value Market Share by Country (2021-2032)
Figure 47. United States Children Genetic Disease Diagnosis Consumption Value (2021-2032) & (USD Million)
Figure 48. Canada Children Genetic Disease Diagnosis Consumption Value (2021-2032) & (USD Million)
Figure 49. Mexico Children Genetic Disease Diagnosis Consumption Value (2021-2032) & (USD Million)
Figure 50. Europe Children Genetic Disease Diagnosis Consumption Value Market Share by Type (2021-2032)
Figure 51. Europe Children Genetic Disease Diagnosis Consumption Value Market Share by Application (2021-2032)
Figure 52. Europe Children Genetic Disease Diagnosis Consumption Value Market Share by Country (2021-2032)
Figure 53. Germany Children Genetic Disease Diagnosis Consumption Value (2021-2032) & (USD Million)
Figure 54. France Children Genetic Disease Diagnosis Consumption Value (2021-2032) & (USD Million)
Figure 55. United Kingdom Children Genetic Disease Diagnosis Consumption Value (2021-2032) & (USD Million)
Figure 56. Russia Children Genetic Disease Diagnosis Consumption Value (2021-2032) & (USD Million)
Figure 57. Italy Children Genetic Disease Diagnosis Consumption Value (2021-2032) & (USD Million)
Figure 58. Asia-Pacific Children Genetic Disease Diagnosis Consumption Value Market Share by Type (2021-2032)
Figure 59. Asia-Pacific Children Genetic Disease Diagnosis Consumption Value Market Share by Application (2021-2032)
Figure 60. Asia-Pacific Children Genetic Disease Diagnosis Consumption Value Market Share by Region (2021-2032)
Figure 61. China Children Genetic Disease Diagnosis Consumption Value (2021-2032) & (USD Million)
Figure 62. Japan Children Genetic Disease Diagnosis Consumption Value (2021-2032) & (USD Million)
Figure 63. South Korea Children Genetic Disease Diagnosis Consumption Value (2021-2032) & (USD Million)
Figure 64. India Children Genetic Disease Diagnosis Consumption Value (2021-2032) & (USD Million)
Figure 65. Southeast Asia Children Genetic Disease Diagnosis Consumption Value (2021-2032) & (USD Million)
Figure 66. Australia Children Genetic Disease Diagnosis Consumption Value (2021-2032) & (USD Million)
Figure 67. South America Children Genetic Disease Diagnosis Consumption Value Market Share by Type (2021-2032)
Figure 68. South America Children Genetic Disease Diagnosis Consumption Value Market Share by Application (2021-2032)
Figure 69. South America Children Genetic Disease Diagnosis Consumption Value Market Share by Country (2021-2032)
Figure 70. Brazil Children Genetic Disease Diagnosis Consumption Value (2021-2032) & (USD Million)
Figure 71. Argentina Children Genetic Disease Diagnosis Consumption Value (2021-2032) & (USD Million)
Figure 72. Middle East & Africa Children Genetic Disease Diagnosis Consumption Value Market Share by Type (2021-2032)
Figure 73. Middle East & Africa Children Genetic Disease Diagnosis Consumption Value Market Share by Application (2021-2032)
Figure 74. Middle East & Africa Children Genetic Disease Diagnosis Consumption Value Market Share by Country (2021-2032)
Figure 75. Turkey Children Genetic Disease Diagnosis Consumption Value (2021-2032) & (USD Million)
Figure 76. Saudi Arabia Children Genetic Disease Diagnosis Consumption Value (2021-2032) & (USD Million)
Figure 77. UAE Children Genetic Disease Diagnosis Consumption Value (2021-2032) & (USD Million)
Figure 78. Children Genetic Disease Diagnosis Market Drivers
Figure 79. Children Genetic Disease Diagnosis Market Restraints
Figure 80. Children Genetic Disease Diagnosis Market Trends
Figure 81. Porters Five Forces Analysis
Figure 82. Children Genetic Disease Diagnosis Industrial Chain
Figure 83. Methodology
Figure 84. Research Process and Data Source